TY  - GEN
AU  - von Laffert,M
AU  - Schirmacher,P
AU  - Warth,A
AU  - Weichert,W
AU  - Büttner,R
AU  - Huber,R M
AU  - Wolf,J
AU  - Griesinger,F
AU  - Dietel,M
AU  - Grohé,Ch
TI  - ALK-Testing in non-small cell lung cancer (NSCLC): Immunohistochemistry (IHC) and/or fluorescence in-situ Hybridisation (FISH)?: Statement of the Germany Society for Pathology (DGP) and the Working Group Thoracic Oncology (AIO) of the German Cancer Society e.V. (Stellungnahme der Deutschen Gesellschaft für Pathologie und der AG Thorakale Onkologie der Arbeitsgemeinschaft Onkologie/Deutsche Krebsgesellschaft e.V.)
SN  - 1872-8332
PY  - 2017///1031
KW  - Algorithms
KW  - Anaplastic Lymphoma Kinase
KW  - Carcinoma, Non-Small-Cell Lung
KW  - genetics
KW  - Crizotinib
KW  - Disease Progression
KW  - Gene Rearrangement
KW  - Germany
KW  - Humans
KW  - Immunohistochemistry
KW  - methods
KW  - In Situ Hybridization, Fluorescence
KW  - Lung Neoplasms
KW  - Oncogene Proteins, Fusion
KW  - Protein Kinase Inhibitors
KW  - therapeutic use
KW  - Pyrazoles
KW  - Pyridines
KW  - Receptor Protein-Tyrosine Kinases
KW  - Survival
KW  - Translocation, Genetic
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1016/j.lungcan.2016.11.008
ER  -